Atorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritis (Q43218018)

16 November 2017

title

Atorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritis (English)

1 reference

16 November 2017

1 reference

7

1 reference

16 November 2017

Philipp Eller

1

1 reference

16 November 2017

Kathrin Eller

2

1 reference

16 November 2017

Anna M Wolf

3

1 reference

16 November 2017

Sebastian J Reinstadler

4

1 reference

16 November 2017

Andrea Tagwerker

5

1 reference

16 November 2017

Josef R Patsch

6

1 reference

16 November 2017

Alexander R Rosenkranz

8

1 reference

16 November 2017

language of work or name

English

0 references

publication date

16 December 2009

1 reference

16 November 2017

1 reference

16 November 2017

volume

77

1 reference

16 November 2017

issue

5

1 reference

16 November 2017

page(s)

428-435

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2009.478

16 November 2017

exact match

0 references

cites work

Isoprenoids as mediators of the biological effects of statins

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Statins induce regulatory T cell recruitment via a CCL1 dependent pathway.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

A novel anti-inflammatory role for simvastatin in inflammatory arthritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Simvastatin protection against acute immune-mediated glomerulonephritis in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Rosuvastatin is additive to high-dose candesartan in slowing progression of experimental mesangioproliferative glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

The role of geranylgeranylated proteins in human mesangial cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Conditional ablation of macrophages halts progression of crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Protein geranylgeranylation regulates the balance between Th17 cells and Foxp3+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Interleukin-10 production by effector T cells: Th1 cells show self control

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Graft-versus-host disease: suppression by statins.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Th17 cytokines and their emerging roles in inflammation and autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

HMG-CoA Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Intrarenal antigens activate CD4+ cells via co-stimulatory signals from dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Differential effects of rapamycin in anti-GBM glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

P-selectin deficiency exacerbates experimental glomerulonephritis: a protective role for endothelial P-selectin in inflammation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression of human scavenger receptor class B type I.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Acute passive anti-glomerular basement membrane nephritis in P-selectin-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.478

7 January 2021

Identifiers

DOI

10.1038/KI.2009.478

1 reference

16 November 2017

1 reference